{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:29:08Z","timestamp":1790389748580,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Topics in Companion Animal Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1053\/j.tcam.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T23:07:27Z","timestamp":1551913647000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study"],"prefix":"10.1053","volume":"35","author":[{"given":"Claudia","family":"Amalfitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Pasolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Della Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Fiorentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lamagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lamagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.tcam.2019.03.001_bib0001","first-page":"683","article-title":"The causes, diagnosis and treatment of canine keratoconjunctivitis sicca","volume":"97","author":"Carter","year":"2002","journal-title":"Vet Med"},{"key":"10.1053\/j.tcam.2019.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2460\/javma.1971.158.09.1566","article-title":"Keratoconjunctivitis sicca in dogs","volume":"158","author":"Aguirre","year":"1971","journal-title":"J Am Vet Med Assoc"},{"key":"10.1053\/j.tcam.2019.03.001_bib0003","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00055735-200408000-00004","article-title":"Dry eye diagnosis and management in 2004","volume":"15","author":"Perry","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0004","first-page":"624","article-title":"Keratoconjunctivitis sicca in dogs. Transactions section on ophthalmology","volume":"81","author":"Helper","year":"1976","journal-title":"Am Acad Ophthalmol Otolaryngol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cvsm.2007.12.002","article-title":"Immunopathogenesis of keratoconjunctivitis sicca in the dog","volume":"38","author":"Williams","year":"2008","journal-title":"Vet Clin N Am: Small Anim Pract"},{"key":"10.1053\/j.tcam.2019.03.001_bib0006","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/978-1-4615-5359-5_132","article-title":"Survey of canine tear deficiency in veterinary practice","volume":"438","author":"Kaswan","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0007","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0090-1229(79)90052-7","article-title":"A disorder of dogs resembling Sj\u00f6gren's syndrome","volume":"12","author":"Quimby","year":"1979","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2460\/ajvr.1984.45.01.112","article-title":"Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan","year":"1984","journal-title":"Am J Veterinary Res"},{"key":"10.1053\/j.tcam.2019.03.001_bib0009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","article-title":"The role of lacrimal functional unit in the pathophysiology of the dry eye","volume":"78","author":"Stern","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1053\/j.tcam.2019.03.001_bib0010","first-page":"240","article-title":"Dry eye: an inflammatory ocular disease","volume":"9","author":"Hessen","year":"2014","journal-title":"J Ophthalmic Vision Res"},{"key":"10.1053\/j.tcam.2019.03.001_bib0011","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0012","first-page":"120","article-title":"Expression of CD40 and CD40 ligand in the human conjunctival epithelium","volume":"41","author":"Bourcier","year":"2000","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0013","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0014","first-page":"1458","article-title":"et al. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation","volume":"38","author":"Baudouin","year":"1997","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/978-1-4615-0717-8_144","article-title":"Impaired neurotransmission in lacrimal and salivary glands of a murine model of Sjogren's syndrome","volume":"506","author":"Zoukhri","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0161-6420(90)32478-8","article-title":"Conjunctival cytologic features of primary Sjogren's syndrome","volume":"97","author":"Pflugfelder","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1053\/j.tcam.2019.03.001_bib0017","first-page":"2567","article-title":"Cytokines in autoimmune lacrimal gland disease in MRL\/MpJ mice","volume":"42","author":"Jabs","year":"2001","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0018","series-title":"Gelatt's Veterinary Ophthalmology","first-page":"415","article-title":"Clinical pharmacology and therapeutics. Anti-inflammatory and immunosuppressant drugs","author":"Rankin","year":"2013"},{"issue":"3","key":"10.1053\/j.tcam.2019.03.001_bib0019","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1463-5224.2010.00858.x","article-title":"Superficial Corneal squamous cell carcinoma occurring in dogs with chronic keratitis","volume":"14","author":"Dreyfus","year":"2011","journal-title":"Vet Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","article-title":"The role and treatment of inflammation in dry eye disease","volume":"34","author":"Yagci","year":"2014","journal-title":"Int Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","article-title":"Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies","volume":"11","author":"Alves","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1053\/j.tcam.2019.03.001_bib0022","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3346\/jkms.2015.30.12.1856","article-title":"The toxicity of nonsteroidal anti-inflammatory eye drops against human corneal epithelial cells in vitro","volume":"30","author":"Lee","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clae.2009.11.002","article-title":"Essential fatty acids for dry eye: a review","volume":"33","author":"Roncone","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1053\/j.tcam.2019.03.001_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00003226-200303000-00002","article-title":"Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component","volume":"22","author":"Barabino","year":"2003","journal-title":"Cornea"},{"key":"10.1053\/j.tcam.2019.03.001_bib0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovi\u0107","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.tcam.2019.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/ICO.0b013e318299549c","article-title":"Long-term supplementation with n-6 and n-3 PUFAs improves moderate to severe keratoconjunctivitis sicca: a randomized double-blind clinical trial","volume":"32","author":"Sheppard","year":"2013","journal-title":"Cornea"},{"key":"10.1053\/j.tcam.2019.03.001_bib0027","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2147\/OPTH.S22647","article-title":"Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A","volume":"5","author":"Jackson","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0028","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jfo.2011.01.018","article-title":"Efficacy assessment of Nutrilarm\u00ae, a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome","volume":"34","author":"Creuzot-Garcher","year":"2011","journal-title":"J Fr Ophtalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0029","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3945\/jn.109.118901","article-title":"Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye","volume":"140","author":"Larmo","year":"2010","journal-title":"J Nutr"},{"key":"10.1053\/j.tcam.2019.03.001_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clae.2015.01.007","article-title":"Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye","volume":"38","author":"Bhargava","year":"2015","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1053\/j.tcam.2019.03.001_bib0031","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0181-5512(06)70106-1","article-title":"Improvement of dry eye symptoms with polyunsaturated fatty acids","volume":"29","author":"Creuzot","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0032","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ophtha.2013.04.006","article-title":"Short-term consumption of oral omega-3 and dry eye syndrome","volume":"120","author":"Kangari","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1053\/j.tcam.2019.03.001_bib0033","first-page":"811","article-title":"A randomized controlled trial of omega-3 fatty acids in dry eye syndrome","volume":"6","author":"Bhargava","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0034","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICO.0b013e3181f22e03","article-title":"Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye","volume":"30","author":"Wojtowicz","year":"2011","journal-title":"Cornea"},{"key":"10.1053\/j.tcam.2019.03.001_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-5224.2005.04062.x","article-title":"The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study","volume":"8","author":"Nell","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0037","first-page":"225","article-title":"Research update of effectiveness and mechanism of essential fatty acids in treating dry eye","volume":"53","author":"Liu","year":"2017","journal-title":"Chin J Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0038","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0039","first-page":"1","article-title":"Effectiveness test: anti-inflammatory action of the F.A.G. (Fatty Acids Group)","volume":"1","author":"D\u2019 Abrosca","year":"2016","journal-title":"J Res Therapy"},{"key":"10.1053\/j.tcam.2019.03.001_bib0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.86.8.879","article-title":"Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sj\u00f6gren's syndrome patients","volume":"86","author":"Aragona","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0041","first-page":"S32","article-title":"Reduction in keratitis and CD44 expression in dry eye patients treated with a unique 0.18% sodium hyaluronate solution. (ARVO abstract)","volume":"42","author":"Baudouin","year":"2001","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1053\/j.tcam.2019.03.001_bib0042","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/vop.12436","article-title":"Assessment of tear film osmolarity using the TearLabTM osmometer in normal dogs and dogs with keratoconjunctivitis sicca","volume":"20","author":"Sebbag","year":"2017","journal-title":"Vet Ophthalmol"},{"key":"10.1053\/j.tcam.2019.03.001_bib0043","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/02713683.2011.571357","article-title":"Tear osmolarity measurements in dry eye related to primary Siogren's syndrome","volume":"36","author":"Utine","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1053\/j.tcam.2019.03.001_bib0044","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/ICO.0b013e31827e2a5e","article-title":"Tear osmolarity in Sjogren syndrome","volume":"32","author":"Bunya","year":"2013","journal-title":"Cornea"},{"key":"10.1053\/j.tcam.2019.03.001_bib0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/ICO.0b013e3182532047","article-title":"Evaluation of tear osmolarity in non-Sjogren and Sjogren syndrome dry eye patients with the TearLab system","volume":"31","author":"Szalai","year":"2012","journal-title":"Cornea"},{"key":"10.1053\/j.tcam.2019.03.001_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocular Surf"}],"container-title":["Topics in Companion Animal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973618302071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973618302071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:37:52Z","timestamp":1761849472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1938973618302071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"alternative-id":["S1938973618302071"],"URL":"https:\/\/doi.org\/10.1053\/j.tcam.2019.03.001","relation":{},"ISSN":["1938-9736"],"issn-type":[{"value":"1938-9736","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study","name":"articletitle","label":"Article Title"},{"value":"Topics in Companion Animal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.tcam.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}